Genmab — November 2019

[Sukkeralf]

Probably just talking gibberish

[E_L]

thinking out-loud; given your concern on damaging the MM franchise with Dara solid trial; could they wait for HexaBody-CD38 and try it with that..?

[Sukkeralf]

Yes and no for you could end up the same way that deaths in a solid trial could jepardize the LCM in MM

[Bulder]

From the press announcement: "Next-generation HexaBody-CD38 could potentially add to the DARZALEX multiple myeloma franchise and expand the potential of CD38-targeted therapies in further indications" - could be solids

[Helge_LarsenPI-redaktør]

Kære venner. Jeg mangler i den grad spørgsmål til Q&A. Håber at de kommer hurtigst muligt.

[Bulder]

You had a Q at 10:41 E L

[E_L]

well ok then, i already asked when he expects to start the first trial, i'll also ask if he thinks it will make for a better option with solids

[Sukkeralf]

Vi skulle da også gerne snart se en IND/CTA for DuoHexa-CD37

[E_L]

maybe it is already in the report tomorrow, we have seen that before, they don't always do a separate press release

[Sukkeralf]

Agree - but that would be nice

[Solsen]

Vi skal nok levere spørgsmål Helge

[Sukkeralf]

Nogen forventninger til ASH abstracts i morgen:

[Sukkeralf]

https://www.hematology.org/Annual-Meeting/Abstracts/

[bibob]

Nok ikke så høje i år.

[Helge_LarsenPI-redaktør]

Tusinde tak Solsen. Jeg har Oncology i morgen, Genmab på Fredag og Zealand sener på måneden. Det trækker tænder ud i en allerede juletravl tid i produktion, grossist- og detailbranchen.

[Relax]

Hej Helge. Har lagt et spørgsmål til Genmabs kommende
Q&A på Genmab Q&A.

[Solsen]

Det første fra mig er sendt

[Solsen]

...og der kommer flere

[Helge_LarsenPI-redaktør]

Super Relax og Solsen.

[Bulder]

cd3xcd20 er jo allerede indsendt til ASH, så måske vil vi allerede kunne få en fornemmelse af styrken i morgen.